Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$13.58 - $17.36 $14,938 - $19,096
-1,100 Reduced 9.17%
10,900 $171,000
Q4 2023

Feb 14, 2024

BUY
$10.11 - $16.54 $116,265 - $190,210
11,500 Added 2300.0%
12,000 $194,000
Q3 2023

Nov 14, 2023

BUY
$12.46 - $15.48 $6,230 - $7,740
500 New
500 $6,000
Q3 2022

Nov 14, 2022

BUY
$12.38 - $20.23 $233,982 - $382,347
18,900 New
18,900 $350,000

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.